The "floor price" heart stent landed smoothly, just the beginning

Pharmaceutical Network February 5th, with the deepening of the reform of the medical and health system, in recent years more and more price-cutting drugs, and medical device supplies price reduction, but also just in the past month, a full landing, including the people are very concerned about the heart stent (also known as the coronary stent).
the use of the national collection heart support landing in a month? In the face of still false high-value medical supplies, how will the collection mechanism work? Some experts believe that the heart stent after the price reduction of all parties have responded well, the reform has received the desired effect.
from the experience of this collection, the heart stent bargaining success, but the first step to reduce the price of Huimin.
"cheap no good goods" is the general psychology, the average price of heart stents from tens of thousands of yuan down to 700 yuan, it is inevitable that people will have doubts.
Although the relevant departments have good reason to argue that "price reduction does not reduce quality", but the people still believe that "see for real", after the successful bargaining quality supervision, product supply and so on every step must go well.
is gratifying that the market reaction after the price reduction of the bracket responds to social concerns with facts.
this time, many places are "sun" out of the low-cost bracket after the local market use.
doctors highly recognized, patients overflowed with words, statistics show that stent use is in a reasonable range of fluctuations, all prove that the heart stent collection has been tested by practice.
by compressing the intermediate circulation link, the income of the front-end enterprise is not significantly affected, but the end patients benefit greatly.
addition, the middlemen disappeared, but also make the medical industry more clean, medical behavior more realistic and pragmatic.
price reduction is "a good start", but this is only the beginning.
The price is abnormally high high-value medical supplies a lot, in addition to the heart stent, there are teeth, artificial crystals, artificial joints, artificial vertebrae, interventional balloons, ablation catheters, pacemakers, etc. , each of these supplies are well received by the public, should be forced to squeeze out the price of water.
bracket collection bears the heavy responsibility of road exploration and needs to play a leading role.
, a scientific model of concentrated recruitment of medical supplies is more to look forward to than the "diving" of bracket prices.
drug supplies price reduction is an important part of medical price reform, concentrated recruitment makes drug supplies significantly lower prices, without increasing the burden of patients, for the reasonable increase in the price of medical technology services to create favorable conditions.
"floor price" heart stent smooth landing results benefit all parties, but focus on the entire medical supplies market, some of the high prices of supplies phenomenon has not changed fundamentally, bracket price reduction just opened the door to supplies collection, there is still a long way to go.
look at the overall picture of health care reform, health care price reform may usher in the best window period, the opportunity is fleeting, chemo for the effectiveness of the matter and complacent.
seize the opportunity, bravely shoulder the burden of reform, in order to continue the good momentum, a drum to crack the medical price burden heavy this difficult problem.
(Luo Zhihua, Department of Physicians)